Literature DB >> 17330839

Renal diagnosis of chronic hemodialysis patients with urinary tract transitional cell carcinoma in Taiwan.

Chung-Hsin Chang1, Cheng-Ming Yang, An-Hang Yang.   

Abstract

BACKGROUND: Transitional cell carcinoma (TCC) is the most common malignancy in dialysis patients of Taiwan. The reason for such a high incidence of TCC is undetermined. The correlation between the underlying renal disease and the development of TCC was investigated.
METHODS: The authors retrospectively reviewed the clinical data and outcome of 1537 chronic hemodialysis (HD) patients from 1993 to 2002. The incidence of TCC was computed. The Cox regression method was used to analyze the role of potential risk factors.
RESULTS: After a mean dialysis duration of 46.5 months, 26 (1.69%) patients with TCC were diagnosed. The standardized incidence ratio (SIR) of TCC was 48.2 as compared with the general population and the SIR of TCC seemed higher in women (65.1) and in the age group 50 to 54 years (173.6). Of them, most cases showed no definite etiology. All these cases showed bilateral contracted kidneys. Nonnephrotic proteinuria was found in all cases and trace glucosuria was found in 17 (65%). Painless gross hematuria was the cardinal symptom and distant metastasis was rare. Also, TCC in upper urinary tracts were common and found in 14 (54%) of patients. Age at the time of dialysis, female sex, compound analgesic use, and Chinese herb use had statistical significance as risk factors (P < .05).
CONCLUSIONS: Chronic HD patients have a high risk of TCC in Taiwan, especially in female and middle-aged patients. The study indicated that chronic tubulointerstitial nephritis (CTIN) is the most likely underlying renal disease in HD patients with TCC, a high percentage of the CTIN related to the usage of Chinese herbs or compound analgesics may contribute to the development of TCC, whereas diabetes or chronic glomerulonephritis play only a minor role.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17330839     DOI: 10.1002/cncr.22557

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  20 in total

1.  Long-term outcome of radical cystectomy in ESDR patients with bladder urothelial carcinoma.

Authors:  Shu-Fen Tseng; Yao-Chi Chuang; Wen-Chou Yang
Journal:  Int Urol Nephrol       Date:  2011-04-24       Impact factor: 2.370

2.  Gender effect on renal outcome in patients with urothelial carcinoma.

Authors:  Peir-Haur Hung; Cheng-Huang Shen; Hung-Bin Tsai; Chih-Yen Hsiao; Pei-Chun Chiang; How-Ran Guo; Kuan-Yu Hung
Journal:  World J Urol       Date:  2011-05-19       Impact factor: 4.226

3.  Aristolochic acid-containing Chinese herbal medicine and upper urinary tract urothelial carcinoma in Taiwan: a narrative review.

Authors:  Kathleen G Dickman; Chung-Hsin Chen; Arthur P Grollman; Yeong-Shiau Pu
Journal:  World J Urol       Date:  2022-07-22       Impact factor: 3.661

4.  A population-based study on the association between urinary calculi and kidney cancer.

Authors:  Shiu-Dong Chung; Shih-Ping Liu; Herng-Ching Lin
Journal:  Can Urol Assoc J       Date:  2013 Nov-Dec       Impact factor: 1.862

5.  Chronic kidney disease as an important risk factor for tumor recurrences, progression and overall survival in primary non-muscle-invasive bladder cancer.

Authors:  Chia-En Li; Chia-Shen Chien; Yao-Chi Chuang; Ye-In Chang; Hsiu-Pei Tang; Chih-Hsiung Kang
Journal:  Int Urol Nephrol       Date:  2016-03-19       Impact factor: 2.370

Review 6.  Risk assessment of upper tract urothelial carcinoma related to aristolochic acid.

Authors:  Felicia Wu; Tianxiu Wang
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-03-05       Impact factor: 4.254

7.  A modified single mini-incision complete urinary tract exenteration for urothelial carcinoma in dialysis patients.

Authors:  I-Hsuan Chen; Jen-Tai Lin; Jeng-Yu Tsai; Tony Wu; Chia-Cheng Yu
Journal:  Biomed Res Int       Date:  2014-08-11       Impact factor: 3.411

8.  Renal expression of hypoxia inducible factor-1α in patients with chronic kidney disease: a clinicopathologic study from nephrectomized kidneys.

Authors:  Tung-Wei Hung; Jia-Hung Liou; Kun-Tu Yeh; Jen-Pi Tsai; Sheng-Wen Wu; Hui-Chun Tai; Wei-Tse Kao; Shu-Hui Lin; Ya-Wen Cheng; Horng-Rong Chang
Journal:  Indian J Med Res       Date:  2013-01       Impact factor: 2.375

9.  Increased risk of urinary tract cancer in ESRD patients associated with usage of Chinese herbal products suspected of containing aristolochic acid.

Authors:  Shuo-Meng Wang; Ming-Nan Lai; Alan Wei; Ya-Yin Chen; Yeong-Shiau Pu; Pau-Chung Chen; Jung-Der Wang
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

Review 10.  Upper tract urothelial carcinomas in patients with chronic kidney disease: relationship with diagnostic challenge.

Authors:  Li-Jen Wang; Shen-Yang Lee; Bin Tean Teh; Cheng-Keng Chuang; Joëlle Nortier
Journal:  Biomed Res Int       Date:  2014-08-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.